Joseph Keenan - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Joseph Keenan's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Joseph Keenan

Joseph Keenan

Verified

Contributing Editor, Fierce Biotech

Dublin

Final Covers

Science Medicine Health PharmaBiotech

Doesn’t Cover

Lifestyle, crime

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 1182

  • Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant

    By Joseph Keenan Verified| FiercePharma Verified Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key regulatory hurdle at its flagship production plant in the United Kingdom. The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Moderna a manufacturer and importer's license at its vaccine facility in Harwell, Oxfordshire.

    By Joseph Keenan Verified · FiercePharma

    Apr. 17, 2025

  • Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant

    By Joseph Keenan Verified| FiercePharma Verified Aurobindo's manufacturing operations have once again landed the Indian drugmaker in hot water with the U.S. FDA. Aurobindo's subsidiary Aurolife Pharma received a Form 483 from the FDA outlining 11 observations at a U.S. production plant, the Indian drugmaker said in a filing late last week. The exact nature of the infractions remain unclear, as the FDA has not published the document.

    By Joseph Keenan Verified · FiercePharma

    Apr. 14, 2025

  • Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant

    By Joseph Keenan Verified| FiercePharma Verified Furthering its goal to grow the reach of its mRNA vaccines and guard against future pandemics, Moderna cleared a key regulatory hurdle at its flagship production plant in the United Kingdom. The U.K.'s Medicines and Healthcare products Regulatory Agency (MHRA) has granted Moderna a manufacturer and importer's license at its vaccine facility in Harwell, Oxfordshire.

    By Joseph Keenan Verified · FiercePharma

    Apr. 17, 2025

As seen in

Company Info

Fierce Biotech

County Dublin